EUVIMEDEUVIMED entdecken
Crossref

Vilazodone as a Novel Anticonvulsant: A Preclinical Evaluation in Experimental Seizure Models

International Journal of Medicine · 24.03.2026 · 8 (3) · 706-710

DOI: 10.61336/im/26-3-106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medicine, online erschienen am 24.03.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epilepsy is one of the most common neurological abnormalities worldwide. Current antiepileptic drugs have limitations in efficacy and safety. Studies have shown decreased serotonin level can induce epileptic seizures in animal models. Vilazodone possess dual mechanism on serotonin by inhibit its reuptake and partial agonistic action on 5-HT1A receptors, it enhances the extracellular serotonin levels in brain.

Objective

To evaluate the anticonvulsant effect of vilazodone in acute seizure models and compare it with sodium valproate.

Methods

A preclinical experimental study was conducted on 36 Swiss albino mice divided into six groups (n=6). Vilazodone (1, 2, 5, 10 mg/kg), sodium valproate (40 mg/kg), and control were administered orally. Seizures were induced using maximal electroshock (MES) and pentylenetetrazole (PTZ) models. Outcomes included duration of tonic hind limb extension, seizure duration and latency.

Results

All doses of Vilazodone significantly reduced tonic hind limb extension in MES and decreased seizure duration in PTZ models. Vilazodone showed increased seizure latency in PTZ model at all doses with maximum increase seen in higher doses (5mg/kg and 10mg/kg).

Conclusion

Vilazodone demonstrates dose-dependent anticonvulsant activity, suggesting potential as an adjunct therapy in epilepsy.

Zitieren

APA

(2026). Vilazodone as a Novel Anticonvulsant: A Preclinical Evaluation in Experimental Seizure Models. International Journal of Medicine, 8(3), 706-710. https://doi.org/10.61336/im/26-3-106

Vancouver

Vilazodone as a Novel Anticonvulsant: A Preclinical Evaluation in Experimental Seizure Models. International Journal of Medicine. 2026;8(3):706-710. doi:10.61336/im/26-3-106

BibTeX
@article{euvimed2026,
  title = {Vilazodone as a Novel Anticonvulsant: A Preclinical Evaluation in Experimental Seizure Models},
  journal = {International Journal of Medicine},
  year = {2026},
  volume = {8},
  number = {3},
  pages = {706--710},
  doi = {10.61336/im/26-3-106}
}
Kostenlos starten →